Australia approves MINJUVI® (tafasitamab) for treatment of relapsed or refractory follicular lymphoma

Biopharmaceutical company Specialised Therapeutics (ST), based in Singapore, has announced that Minjuvi® (tafas...

April 23, 2026 | Thursday | News
TJ Biopharma enters into agreement with Biogen for Felzartamab assets in Greater China Region

Biogen Inc. and TJ Biopharma have entered into a definitive agreement under which Biogen has agreed to acquire TJ B...

April 22, 2026 | Wednesday | News
Santen bags China rights to 5 glaucoma drugs from AbbVie

Santen Pharmaceutical Co. has announced that Santen China has entered into a distribution and promotion agreement with A...

April 21, 2026 | Tuesday | News
Freudenberg Medical launches ISO Class 5 controlled cleanroom for sterile single-use assemblies

Germany-based Freudenberg Medical, a global contract design and manufacturing partner to the medical device and bio...

April 20, 2026 | Monday | News
Japan's Takeda terminates mRNA-targeted small-molecule drugs research pact with Veritas

Japan-based Veritas In Silico Inc. (VIS) has been conducting a collaborative drug discovery research on mRNA-targeted sm...

April 18, 2026 | Saturday | News
Lilly acquires Kelonia Therapeutics for $7 B to advance in vivo CAR-T cell therapies

US-based Eli Lilly and Company, and Kelonia Therapeutics, Inc., a US-based clinical-stage biotechnology company pio...

April 21, 2026 | Tuesday | News
Mabwell establishes licensing and commercialisation agreement for Denosumab Biosimilars in Malaysia

Mabwell, a China-based innovation-driven biopharmaceutical company with a fully integrated industry chain, has establish...

April 18, 2026 | Saturday | News
Axtria acquires Conexus Solutions to redefine life sciences commercialisation

US-based Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, has anno...

April 16, 2026 | Thursday | News
Taiwan's Senhwa Biosciences secures funding upto NT$500 M to accelerate AI-driven drug development

Senhwa Biosciences, Inc., a Taiwan-based clinical-stage biopharmaceutical company, has announced the signing of a Memora...

April 14, 2026 | Tuesday | News
Aragen launches ‘ChemiSHE’, India’s first women-led chemistry synthesis laboratory

Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has launched Chemi...

April 13, 2026 | Monday | News
Australia's Telix Pharma announces strategic radiopharma collaboration worth $535 M with Regeneron

Australia-based Telix Pharmaceuticals and US-based Regeneron Pharmaceuticals, Inc. have announced a collaboration to joi...

April 13, 2026 | Monday | News
Gan & Lee inks agreement with JW Pharma to advance global commercialisation of GLP-1 receptor agonist Bofanglutide

Gan & Lee Pharmaceuticals has announced the signing of an exclusive licensing agreement with JW Pharmaceutical, a le...

April 10, 2026 | Friday | News
Lonza Redefines Bioprocess Efficiency In APAC With Advanced Media Development Lab

  As biologics pipelines grow more complex and timelines tighten, early stage process decisions are becoming criti...

April 9, 2026 | Thursday | Opinion
Meiji Pharma Asia commences operations in Singapore

Japan's Meiji Seika Pharma has announced that its local subsidiary, Meiji Pharma Asia has commenced operations in S...

April 8, 2026 | Wednesday | News
Mochida grants LG Chem rights to develop & market Dinagest in South Korea and Thailand

Japan-based Mochida Pharmaceutical and LG Chem, based in South Korea, have entered into a partnership agreement for Dina...

April 7, 2026 | Tuesday | News
Taiwan's Lotus Pharmaceutical buys Sandoz AG’s Philippines business

Taiwan based Lotus Pharmaceutical has entered into an agreement to acquire Sandoz AG’s Philippines business. Subje...

April 3, 2026 | Friday | News
NJ Bio collaborates with Ajinomoto Bio‑Pharma to strengthen support for ADC development

US-based NJ Bio, Inc., a leading provider of integrated drug discovery and development services and Japan's Ajinomoto Bi...

April 2, 2026 | Thursday | News
South Korea’s Biosimilar Boom Enters High-Stakes ‘Third Wave’

South Korea has a growing biosimilars market. The country has taken an early and active approach to building this indust...

April 1, 2026 | Wednesday | Analysis
Japan's Otsuka Pharma buys Transcend Therapeutics for $1.2 B

Japan-based Otsuka Pharmaceutical and US-based startup Transcend Therapeutics have entered into an agreement, under whic...

March 31, 2026 | Tuesday | News
Japan's Meiji Seika Pharma invests in Centivax to develop next-gen universal vaccine platform

Japan-based Meiji Seika Pharma Co. has announced a strategic investment in Centivax, Inc., a US-based biotechnology comp...

March 30, 2026 | Monday | News
Jamjoom Pharma and Magrabi Health Group sign MoU to enhance ophthalmology services in Saudi Arabia

In a move reflecting their shared commitment to advancing the healthcare sector and elevating the quality of medical ser...

March 30, 2026 | Monday | News
Australia's Clarity inks large-scale manufacturing supply agreement for copper-64 with Theragenics

Clarity Pharmaceuticals, an Australia-based clinical-stage radiopharmaceutical company with a mission to develop ne...

March 26, 2026 | Thursday | News
Roche inaugurates new research home for Institute of Human Biology

Roche has announced the inauguration of the new research home for the Institute of Human Biology (IHB). The opening mark...

March 26, 2026 | Thursday | News
Novartis unveils its investment and expansion plans for China to boost biopharm R&D footprint

Novartis is set to expand its presence in China with an investment exceeding RMB 3.3 billion to bolster R&D, product...

March 25, 2026 | Wednesday | News
Advancing MedTech Packaging Innovation in Asia-Pacific

The medical device and healthcare packaging industry is experiencing significant growth in the Asia-Pacific region, driv...

March 24, 2026 | Tuesday | Opinion